Butterfly Network Inc. recently provided commentary following Midjourney’s public announcement of Midjourney Medical and The Midjourney Scanner: a full-body tomographic imaging machine.
The current scanner prototype incorporates 40 Butterfly Ultrasound-on-Chip imaging modules per system, licensed under a co-development agreement between the two companies. Future generations are expected to utilize substantially more imaging modules, reflecting the platform’s planned evolution and scalability. Additional details regarding the platform and Midjourney’s long-term objectives are available in their announcement: https://www.midjourney.com/medical/blogpost
“After nearly 35 years working in healthcare, it’s clear to me that our U.S. healthcare system is still primarily designed to treat illness, not prevent it. The future of health starts with awareness: understanding your body earlier and tracking how it responds to factors like diet, exercise, and behavior. Midjourney has unveiled an extraordinary whole-body scanner – no radiation, no magnetic risk, low cost, and accessible – with about half a million sensors scanning simultaneously and over two petaflops of processing power. Designed for weekly use, this is the next generation of AI on device. A continuous window into your health … because the earlier you can see what’s changing, the sooner you can do something about it,” said Joseph DeVivo, president, chief executive officer and chairman of Butterfly Network.
DeVivo continued, “We’re proud to support Midjourney’s mission to democratize access to personal imaging data. The vision and roadmap Founder David Holz introduced yesterday also represents a potentially meaningful commercial opportunity for Butterfly, and we look forward to discussing that further with stakeholders later today.”
Butterfly management will discuss the collaboration in more detail at 12:00pm EDT today during an Emerging Growth Webinar with TD Cowen. To register and access, visit: ir.butterflynetwork.com/events-and-presentations.
The collaboration is enabled through Butterfly Embedded, Butterfly’s Ultrasound-on-Chip licensing and co-development business initiative, formerly known as Octiv. Butterfly previously filed the terms of its agreement with Midjourney in a Form 8-K on November 17, 2025, which disclosed up to $74 million in expected payments to Butterfly over a five-year term. Stakeholders are encouraged to refer to that filing for information regarding the agreement.
